SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-13-119763
Filing Date
2013-03-21
Accepted
2013-03-21 17:20:23
Documents
11
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d444117d10k.htm 10-K 1221483
2 EX-23.1 d444117dex231.htm EX-23.1 2922
3 EX-31.1 d444117dex311.htm EX-31.1 9197
4 EX-31.2 d444117dex312.htm EX-31.2 9183
5 EX-32.1 d444117dex321.htm EX-32.1 6378
  Complete submission text file 0001193125-13-119763.txt   7080858

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT abio-20121231.xml EX-101.INS 888059
7 XBRL TAXONOMY EXTENSION SCHEMA abio-20121231.xsd EX-101.SCH 48760
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abio-20121231_cal.xml EX-101.CAL 63333
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abio-20121231_def.xml EX-101.DEF 154266
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20121231_lab.xml EX-101.LAB 401201
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20121231_pre.xml EX-101.PRE 283309
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22873 | Film No.: 13708431
SIC: 2835 In Vitro & In Vivo Diagnostic Substances